Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025)
Vertex Pharmaceuticals (VRTX) posted quarterly Asset Writedowns and Impairment of $379.0 million for Q1 2025, up 4481.5% quarter-over-quarter from -$8.6 million in Q4 2019.
Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends
Vertex Pharmaceuticals' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $379.0 million for Q1 2025.
- In Q1 2025, Asset Writedowns and Impairment changed N/A year-over-year to $379.0 million; the TTM figure through Dec 2025 stood at $379.0 million (changed N/A YoY), while the FY2025 annual figure was $379.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at $379.0 million, up from -$8.6 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $379.0 million in Q1 2025, with the low at $379.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 379.00 Mn |
| Mar 31, 2025 | 379.00 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Dec 31, 2019 | -8.65 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.61 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Jun 30, 2019 | 5.77 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Mar 31, 2019 | 1.27 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Dec 31, 2018 | 29.00 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Sep 30, 2017 | 255.30 Mn |
| Dec 31, 2015 | 2.49 Mn |
| Dec 31, 2015 | 2.49 Mn |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2014 | 711,000.00 |
| Dec 31, 2013 | 250.60 Mn |
| Dec 31, 2013 | 250.60 Mn |